Journal of General Internal Medicine

, Volume 28, Issue 8, pp 1028–1034 | Cite as

Cognitive Enhancement Drug Use Among Future Physicians: Findings from a Multi-Institutional Census of Medical Students

  • Robyn M. Emanuel
  • Sandra L. Frellsen
  • Kathleen J. Kashima
  • Sandra M. Sanguino
  • Frederick S. Sierles
  • Cathy J. Lazarus
Original Research

ABSTRACT

BACKGROUND

Nonmedical use of prescription psychostimulants such as methylphenidate and amphetamine salts for the purpose of cognitive enhancement is a growing trend, particularly in educational environments. To our knowledge, no recent studies have evaluated the use of these psychostimulants in a medical academic setting.

OBJECTIVE

To conduct an online census of psychostimulant use among medical students.

DESIGN

In 2011, we conducted a multi-institutional census using a 31–48 item online survey regarding use of prescription psychostimulants.

PARTICIPANTS

2,732 actively enrolled medical students at four private and public medical schools in the greater Chicago area.

MAIN MEASURES

Prevalence and correlates of psychostimulant use

KEY RESULTS

1,115 (41 %) of students responded to the web-based questionnaire (range 26–47 % among schools). On average, students were 25.1 years of age (SD = 2.7, range 20–49), and single (70 %). Overall, 18 % (198/1,115) of this medical student sample had used prescription psychostimulants at least once in their lifetime, with first use most often in college. Of these, 11 % (117/1,115) of students reported use during medical school (range 7–16 % among schools). Psychostimulant use was significantly correlated with use of barbiturates, ecstasy, and tranquilizers (Pearson’s correlation r > 0.5, Student’s t-test p < 0.01); male gender (21 % male versus 15 % female, Chi squared p = 0.007); and training at a medical school which by student self-report determined class rank (68 % versus 51 %, Chi-squared p = 0.018). Non-users were more likely to be first year students (Chi-squared p = 0.048) or to have grown up outside of the United States (Chi-squared p = 0.013).

CONCLUSIONS

Use of psychostimulants, including use without a prescription, is common among medical students. Further study of the side effects, medical implications, and use during post-graduate medical training and medical practice is needed to inform evidence-based policy.

KEY WORDS

cognitive enhancement nootropics amphetamine salts methylphenidate medical students drug use 

REFERENCES

  1. 1.
    Butcher J. Cognitive enhancement raises ethical concerns. Academics urge pre-emptive debate on neurotechnologies. Lancet. 2003;362(9378):132–3.PubMedCrossRefGoogle Scholar
  2. 2.
    Prescription drug abuse: a fast-growing problem. NIH Medline Plus. 2011;6(3):21.Google Scholar
  3. 3.
    Wilens TE, Adler LA, Adams J, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry. 2008;47(1):21–31.PubMedCrossRefGoogle Scholar
  4. 4.
    Kollins SH. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. J Atten Disord. 2008;12(2):115–25.PubMedCrossRefGoogle Scholar
  5. 5.
    American Academy of Family Physicians Conditions A to Z. Attention Deficit Hyperactivity Disorder (ADHD) and Attention Deficit Disorder (ADD) 2009.; http://online.statref.com/document.aspx?fxid=99&docid=11. Accessed Feburary 23, 2012.
  6. 6.
    Ropper A, Brown R. Adams and Victor’s Principles of Neurology. 8th ed. New York: The McGraw-Hill Publishing Company; 2005.Google Scholar
  7. 7.
    Zeeuws I, Deroost N, Soetens E. Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: evidence from a source memory task. Hum Psychopharmacol. 2010;25(4):326–34.PubMedCrossRefGoogle Scholar
  8. 8.
    Soetens E, Casaer S, D’Hooge R, Hueting JE. Effect of amphetamine on long-term retention of verbal material. Psychopharmacology. 1995;119(2):155–62.PubMedCrossRefGoogle Scholar
  9. 9.
    Zeeuws I, Soetens E. Verbal memory performance improved via an acute administration of D-amphetamine. Hum Psychopharmacol. 2007;22(5):279–87.PubMedCrossRefGoogle Scholar
  10. 10.
    Soetens E, D’Hooge R, Hueting JE. Amphetamine enhances human-memory consolidation. Neurosci Lett. 1993;161(1):9–12.PubMedCrossRefGoogle Scholar
  11. 11.
    Porter RS. The Merk Manual Home Health Handbook. In: Porter RS, ed. Amphetamines: Merk; 2011: http://www.merckmanuals.com/home/special_subjects/drug_use_and_abuse/amphetamines.html?qt=amphetamines&alt=sh. Accessed Feburary 23, 2012.
  12. 12.
    Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA. 2009;301(11):1148–54.PubMedCrossRefGoogle Scholar
  13. 13.
    United States Congress. U.S. Substances Control Act. Vol 84 Stat. 12421970.Google Scholar
  14. 14.
    Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration. Pharmacotherapy. 2006;26(10):1501–10.PubMedCrossRefGoogle Scholar
  15. 15.
    Baldwin DC Jr, Hughes PH, Conard SE, Storr CL, Sheehan DV. Substance use among senior medical students. A survey of 23 medical schools. JAMA. 1991;265(16):2074–8.PubMedCrossRefGoogle Scholar
  16. 16.
    Croen LG, Woesner M, Herman M, Reichgott M. A longitudinal study of substance use and abuse in a single class of medical students. Acad Med. 1997;72(5):376–81.PubMedCrossRefGoogle Scholar
  17. 17.
    Flaherty JA, Richman JA. Substance use and addiction among medical students, residents, and physicians. Psychiatr Clin N Am. 1993;16(1):189–97.Google Scholar
  18. 18.
    Rai D, Gaete J, Girotra S, Pal HR, Araya R. Substance use among medical students: time to reignite the debate? Nat Med J India. 2008;21(2):75–8.Google Scholar
  19. 19.
    Kumar P, Basu D. Substance abuse by medical students and doctors. J Indian Med Assoc. 2000;98(8):447–52.PubMedGoogle Scholar
  20. 20.
    Shyangwa PM, Joshi D, Lal R. Alcohols and other substance use/abuse among junior doctors and medical students in a teaching institute. JNMA. 2007;46(167):126–9.Google Scholar
  21. 21.
    Newbury-Birch D, Walshaw D, Kamali F. Drink and drugs: from medical students to doctors. Drug Alcohol Depend. 2001;64(3):265–70.PubMedCrossRefGoogle Scholar
  22. 22.
    Harris S. “I Don’t See It as a Problem”: More Medical Students Taking Prescription Stimulants, Few See Cause for Concern. AAMC Reporter. 2009;June Edition.Google Scholar
  23. 23.
    Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2011. Annu Vol Trends Drug Use Relat Factors. 2012;2:314.Google Scholar
  24. 24.
    Dutta AP, Pyles MA, Miederhoff PA. Stress in health professions students: myth or reality? A review of the existing literature. J Natl Black Nurses Assoc. 2005;16(1):63–8.PubMedGoogle Scholar
  25. 25.
    Dyrbye LN, Thomas MR, Shanafelt TD. Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical students. Acad Med. 2006;81(4):354–73.PubMedCrossRefGoogle Scholar
  26. 26.
    Dyrbye LN, Thomas MR, Huntington JL, et al. Personal life events and medical student burnout: a multicenter study. Acad Med. 2006;81(4):374–84.PubMedCrossRefGoogle Scholar
  27. 27.
    Webb J, Thomas J, Valaseck M. Contemplating cognitive enhancement in medical students and residents. Perspect Biol Med. 2010;53(2):200–14.PubMedCrossRefGoogle Scholar
  28. 28.
    Goebert D. Depressive symptoms in medical students and residents: a multi-school study. Acad Med. 2009;84(2):236–41.PubMedCrossRefGoogle Scholar
  29. 29.
    Strine TW. Metropolitan and micropolitan statistical area estimates of depression and anxiety using the patient health questionaire-8 in the 2006 behavioral risk factor surveillance system. Int J Public Health. 2009;54(2):117–24.PubMedCrossRefGoogle Scholar
  30. 30.
    Smith ME, Farah MJ. Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychol Bull. 2011;137(5):717–41.PubMedCrossRefGoogle Scholar
  31. 31.
    Greely H, Sahakian B, Harris J, et al. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature. 2008;456(7223):702–5.PubMedCrossRefGoogle Scholar
  32. 32.
    Rose SH, Curry TB. Fatigue, countermeasures, and performance enhancement in resident physicians. Mayo Clin Proc. 2009;84(11):955–7.PubMedGoogle Scholar
  33. 33.
    Marsden P, Wright J. Handbook of Survey Research. 2nd ed: Emerald Publishing Group Limited; 2010.Google Scholar

Copyright information

© Society of General Internal Medicine 2012

Authors and Affiliations

  • Robyn M. Emanuel
    • 1
    • 2
  • Sandra L. Frellsen
    • 3
  • Kathleen J. Kashima
    • 4
  • Sandra M. Sanguino
    • 5
  • Frederick S. Sierles
    • 6
  • Cathy J. Lazarus
    • 7
    • 8
    • 9
  1. 1.Mayo ClinicScottsdaleUSA
  2. 2.Chicago Medical SchoolRosalind Franklin University of Medicine and ScienceNorth ChicagoUSA
  3. 3.Department of Medicine at Rush Medical CollegeRush UniversityChicagoUSA
  4. 4.University of Illinois College of MedicineChicagoUSA
  5. 5.Northwestern University, Feinberg School of MedicineChicagoUSA
  6. 6.Department of Psychiatry and Behavioral SciencesRosalind Franklin University of Medicine and ScienceNorth ChicagoUSA
  7. 7.Tulane University School of MedicineNew OrleansUSA
  8. 8.Southeast Louisiana Veterans Health Care SystemNew OrleansUSA
  9. 9.Rosalind Franklin University of Medicine and ScienceNorth ChicagoUSA

Personalised recommendations